Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response Study of Strontium Malonate in Postmenopausal Women
NCT00409032Phase 2Completed
- Sponsor
- Osteologix
- Start
- Dec 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of strontium malonate in osteoporosis (5 arms), sponsored by Osteologix. Primary endpoint: Serum C-terminal telopeptide of type I collagen at 12 weeks. Started Dec 2006; status: completed.
02
Drugs
strontium malonate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00409032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409032.